Home
Contact Us
About Us
Advertise
Biotech
Finance
Tech News
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
BioPharmaJournal
Home
Contact Us
About Us
Advertise
Biotech
Progenity Inc. (NASDAQ:PROG) Announces Expansion Of COVID-19 RT-PCR Test In The…
TG Therapeutics Inc. (NASDAQ:TGTX) Presents Triple Combination Data At 62nd American…
Ionis Pharmaceuticals Inc. (NASDAQ:IONS) Provides Updates Of Its 2020 Achievements And…
Heron Therapeutics Inc. (NASDAQ:HRTX) Resubmits HTC-011 New Drug Application To The…
Incyte (NASDAQ:INCY) Releases Phase 3 Jakafi® In Combination with SOC Study…
Finance
Bitcoin Stocks for the Win (SQ, RIOT, ISWH, HVBTF)
The Contrarian Opportunity in Sports Stocks (CHDN, DKNG, BTDG, DKS)
Menlo Therapeutics Inc (NASDAQ:MNLO) Reports Positive Data From Phase 2 Clinical…
OSI Systems, Inc. (NASDAQ:OSIS) Bags $5 Million Order For The Supply…
TrialSpark Collaborates with resTORbio, Inc. (NASDAQ:TORC) and Integrates the Project Covalence…
Tech News
Tauriga Sciences Inc (OTCMKTS:TAUG) Could React on New Aegea Rapid Test…
Micro and Macro Tailwinds Converge for KULR
ISWH and the Rebirth of the Crypto Cycle
Home
Tags
NASDAQ:VRTX
Tag: NASDAQ:VRTX
CRISPR Therapeutics (NASDAQ:CRSP) And Vertex Pharmaceuticals (NASDAQ:VRTX) To Present More Data...
Gavins Felicity
-
November 10, 2020
0
Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) Receive Approval From European Commission For Expanded...
Gavins Felicity
-
November 9, 2020
0
CRISPR Therapeutics (NASDAQ:CRSP) and Vertex (NASDAQ:VRTX) Receive Priority Medicines (PRIME) Designation...
Gavins Felicity
-
October 13, 2020
0
Moderna (NASDAQ:MRNA) Enters Licensing And Research Collaborations Agreement With Vertex (NASDAQ:VRTX)...
Gavins Felicity
-
October 5, 2020
0
Vertex (NASDAQ:VRTX) Announce EMA Type II Variation Marketing Authorization Application For...
Kate Hudson
-
September 24, 2020
0
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Announces the FDA’s Acceptance of Supplemental NDAs...
Gavins Felicity
-
September 10, 2020
0
Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) Receives European Commission KALYDECO Approval For Treatment...
Matt Wade
-
June 19, 2020
0
.td-post-views{ display: none !important; }
